MS

Martin E. Sanders

IT Io Therapeutics: 49 patents #2 of 19Top 15%
University Of Texas System: 3 patents #1,041 of 6,559Top 20%
DC Dartmouth College: 2 patents #180 of 689Top 30%
US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
CP Celtrix Pharmaceuticals: 2 patents #21 of 42Top 50%
DC Diatex Co.: 1 patents #15 of 25Top 60%
Stanford University: 1 patents #2,251 of 5,197Top 45%
TC The University Of Chicago: 1 patents #530 of 1,377Top 40%
IB Igm Biosciences: 1 patents #14 of 16Top 90%
ME Metabolex: 1 patents #34 of 50Top 70%
📍 Spring, TX: #17 of 2,039 inventorsTop 1%
🗺 Texas: #1,264 of 125,132 inventorsTop 2%
Overall (All Time): #40,081 of 4,157,543Top 1%
59
Patents All Time

Issued Patents All Time

Showing 51–59 of 59 patents

Patent #TitleCo-InventorsDate
9907768 Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy Roshantha A. Chandraratna 2018-03-06
9877941 Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones Roshantha A. Chandraratna 2018-01-30
9458241 Antibody induced cell membrane wounding Neelima M. Bhat, Marcia M. Bieber, Nelson N. H. Teng 2016-10-04
8377435 Antibody induced cell membrane wounding Neelima M. Bhat, Marcia M. Bieber, Nelson N. H. Teng 2013-02-19
8288438 Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancer David Karpf 2012-10-16
6025368 Method for treating the symptoms of chronic stress-related disorders using IGF Desmond Mascarenhas 2000-02-15
6015786 Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 Desmond Mascarenhas 2000-01-18
4820635 Kit for assaying activation of terminal complement cascade Keith A. Joiner, Michael M. Frank, Carl H. Hammer 1989-04-11
4722890 Quantitative assay for human terminal complement cascade activation Keith A. Joiner, Michael M. Frank, Carl H. Hammer 1988-02-02